NASDAQ: EOLS
Evolus Inc Stock Ownership - Who owns Evolus?

Insider buying vs selling

Have Evolus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David MoatazediPresident and Chief Executive Officer2025-03-276,251$12.40
$77.51kSell
Sandra BeaverChief Financial Officer2025-03-188,996$13.26
$119.24kSell
Tomoko YamagishidresslerChief Marketing Officer2025-03-184,536$13.26
$60.12kSell
David MoatazediDirector2025-03-18103,376$13.26
$1.37MSell
Rui AvelarOfficer2025-03-1827,904$13.26
$369.87kSell
Karah Herdman ParschauerDirector2025-03-1212,888$12.99
$167.47kSell
Sandra BeaverChief Financial Officer2024-12-231,586$10.85
$17.21kSell
Rui AvelarChief Medical Officer Head of Research and Development2024-12-232,252$10.85
$24.44kSell
David MoatazediPresident CEO2024-12-2310,502$10.85
$113.97kSell
Sandra BeaverChief Financial Officer2024-09-063,276$14.98
$49.07kSell

1 of 3

EOLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EOLS insiders and whales buy or sell their stock.

EOLS Shareholders

What type of owners hold Evolus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medytox Inc16.73%10,640,826$114.81MInsider
Perceptive Advisors LLC8.09%5,145,846$55.52MInstitution
Tang Capital Management LLC7.86%4,997,399$53.92MInstitution
Blackrock Inc6.86%4,364,896$47.10MInstitution
Alphaeon 1 LLC6.63%4,214,871$45.48MInsider
Vanguard Group Inc4.99%3,171,404$34.22MInstitution
Nantahala Capital Management LLC4.92%3,130,149$33.77MInstitution
Caligan Partners LP4.23%2,692,388$29.05MInstitution
State Street Corp2.24%1,422,369$15.35MInstitution
Millennium Management LLC2.15%1,368,423$14.77MInstitution

1 of 3

EOLS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EOLS74.49%25.51%Net SellingNet Selling
CRON11.34%49.08%Net SellingNet Selling
PAHC45.01%54.99%Net BuyingNet Buying
AVDL82.18%13.63%Net Buying
ORGO6.08%93.92%Net SellingNet Selling

Evolus Stock Ownership FAQ

Who owns Evolus?

Evolus (NASDAQ: EOLS) is owned by 81.65% institutional shareholders, 27.96% Evolus insiders, and 0.00% retail investors. Medytox Inc is the largest individual Evolus shareholder, owning 10.64M shares representing 16.73% of the company. Medytox Inc's Evolus shares are currently valued at $110.45M.

If you're new to stock investing, here's how to buy Evolus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.